RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of HRTX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Heron Therapeutics stock upgraded to Buy Candidate.
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 13, 2024 Loss -7.97% PDF

The Heron Therapeutics stock price gained 1.09% on the last trading day (Thursday, 28th Mar 2024), rising from $2.74 to $2.77. During the last trading day the stock fluctuated 5.24% from a day low at $2.67 to a day high of $2.81. The price has fallen in 5 of the last 10 days and is down by -9.18% for this period. Volume fell on the last day by -117 thousand shares and in total, 1 million shares were bought and sold for approximately $3.06 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 44.61% during the next 3 months and, with a 90% probability hold a price between $3.69 and $4.64 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

HRTX Signals & Forecast

The Heron Therapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.90. On a fall, the stock will find some support from the long-term average at approximately $2.73. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, March 15, 2024, and so far it has fallen -9.48%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Heron Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.62 and $2.20. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Heron Therapeutics finds support just below today's level at $2.62. If this is broken, then the next support from accumulated volume will be at $2.20 and $2.09.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.140 between high and low, or 5.24%. For the last week, the stock has had daily average volatility of 6.61%.

Our recommended stop-loss: $2.62 (-5.38%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (HRTX) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Heron Therapeutics to open at $2.75, and during the day (based on 14 day Average True Range), to move between $2.55 and $2.99, which gives a possible trading interval of +/-$0.217 (+/-7.85%) up or down from last closing price. If Heron Therapeutics takes out the full calculated possible swing range there will be an estimated 15.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.87 (3.61%) than the support at $2.62 (5.60%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Heron Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Heron Therapeutics stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.335 Buy Candidate Upgraded

Predicted Opening Price for Heron Therapeutics of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$2.75 ( 0.722%) $2.77

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for HRTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.89 4.33 %
R2 2.84 2.40 %
R1 2.80 1.21 %
Current price: 2.77
Support S1 2.70 -2.65 %
S2 2.66 -3.85 %
S3 2.61 -5.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.05 10.11 %
R2 3.01 8.66 %
R1 2.87 3.61 %
Current price 2.77
Support S1 2.62 -5.60%
S2 2.20 -20.58%
S3 2.09 -24.55%

FAQ

What is the symbol for Heron Therapeutics Stock and on which exchange is it traded?
The symbol for Heron Therapeutics is HRTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Heron Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Heron Therapeutics stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Heron Therapeutics Stock?
Heron Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Heron Therapeutics Stock.

What's the current price of Heron Therapeutics Stock?
As of the end of day on the 2024-03-28, the price of an Heron Therapeutics (HRTX) share was $2.77.

What is the 52-week high and low for Heron Therapeutics Stock?
The 52-week high for Heron Therapeutics Stock is $3.22 and the 52-week low is $0.500.

What is the market capitalization of Heron Therapeutics Stock?
As of the 2024-03-28, the market capitalization of Heron Therapeutics is 416.411M.

When is the next earnings date for Heron Therapeutics?
The upcoming earnings date for Heron Therapeutics is May 09, 2024.
Click to get the best stock tips daily for free!

About Heron Therapeutics

Heron Therapeutics Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut... HRTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT